Abstract
Background Since its development, uterine artery embolization (UAE) for the treatment of symptomatic
fibroids has become an established minimally invasive alternative to surgical myoma
treatment. Currently, more than 25,000 myoma patients worldwide are likely to be treated
with UAE annually.
Method Thirty years ago, Jacques-Henri Ravina (b. 1930) and his Paris team first performed
this therapy as a “substitute” for gynecologic surgery. We contacted him as part of
the preparation of the present review. In addition, we performed a literature search
with the aim of summarizing the current literature and data in addition to a historical
account of the development of UAE.
Results and Conclusion On the occasion of this anniversary, we would like to recall the interdisciplinary
roots and some facets of the history of the development of this relatively young myoma
treatment method.
Key points
-
UAE is an established minimally invasive alternative to surgical myoma treatment.
-
UAE was first developed 30 years ago.
-
UAE has continuously increased in importance in recent years.
Citation Format
-
Psilopatis I, Fleckenstein FN, Gebauer B et al. Medical historical notes on myoma
treatment by uterine artery embolization on the occasion of its introduction 30 years
ago. Fortschr Röntgenstr 2023; 195: 890 – 895
Key words
uterus - embolization - leiomyoma
